regadenoson has been researched along with thallium-201 in 1 studies
| Studies (regadenoson) | Trials (regadenoson) | Recent Studies (post-2010) (regadenoson) | Studies (thallium-201) | Trials (thallium-201) | Recent Studies (post-2010) (thallium-201) |
|---|---|---|---|---|---|
| 321 | 53 | 264 | 62 | 2 | 60 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bednárová, V; Kamínek, M; Kincl, V; Máchal, J; Panovský, R; Vašina, J | 1 |
1 other study(ies) available for regadenoson and thallium-201
| Article | Year |
|---|---|
The prognostic value of ultra low-dose thallium myocardial perfusion protocol using CZT SPECT.
Topics: Aged; Cadmium; Coronary Circulation; Disease Progression; Equipment Design; Exercise Test; Female; Gamma Cameras; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Pilot Projects; Predictive Value of Tests; Prognosis; Purines; Pyrazoles; Radiation Dosage; Radiation Exposure; Radiopharmaceuticals; Reproducibility of Results; Tellurium; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Zinc | 2019 |